| Title |
Reversal of Anisocoria in Horner Syndrome Following Commencement of Oral Reboxetine, a Selective Norepinephrine Reuptake Inhibitor |
| Creator |
Blake D. Colman; Anthony J. Fok; Randy H. Kardon |
| Affiliation |
Department of Neuroscience (BDC), Central Clinical School, Faculty of Medicine, Nursing and Health Science, Monash University, Melbourne, Victoria, Australia; Department of Neurology (BDC), Alfred Hospital, Melbourne, Victoria, Australia; Department of Neurology (BDC, AF), Royal Melbourne Hospital, Melbourne, Victoria, Australia; Department of Neuro-Ophthalmology (BDC, AF), Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia; and Department of Ophthalmology and Visual Sciences (RHK), Neuro-Ophthalmology Division, University of Iowa, Iowa City, Iowa |
| Subject |
Administration, Oral; Adrenergic Uptake Inhibitors / therapeutic use; Anisocoria / diagnosis; Anisocoria / etiology; Horner Syndrome / diagnosis; Horner Syndrome / drug therapy; Horner Syndrome / etiology; Humans; Reboxetine |
| Date |
2024-06 |
| Date Digital |
2024-06 |
| References |
Eyding D, Lelgemann M, Grouven U, Harter M, Kromp M, Kaiser T, Kerekes MF, Gerken M, Wieseler B. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ. 2010;341:c4737. Wong EHF, Sonders MS, Amara SG, Tinholt PM, Piercey MF, Hoffmann WP, Hyslop DK, Franklin S, Porsolt RD, Bonsignori A, Carfagna N, McArthur RA. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol Psychiatry. 2000;47:818-829. Rogoz Z, Margas W, Skuza G, Solich J, Kuśmider M, Dziedzicka-Wasylewska M. Effect of repeated treatment with reboxetine on the central alpha 1-adrenergic and dopaminergic receptors. Polish J Pharmacol. 2002;54:593-603. Szabadi E, Bradshaw CM, Boston PF, Langley RW. The human pharmacology of reboxetine. Hum Psychopharmacol Clin Exp. 1998;13:S3-S12. Langham ME, Weinstein G. Horner's syndrome. Ocular supersensitivity to adrenergic amines. Arch Ophthalmol. 1967;78:462-469. |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Publication Type |
Journal Article |
| Source |
Journal of Neuro-Ophthalmology, June 2024, Volume 44, Issue 2 |
| Collection |
Neuro-Ophthalmology Virtual Education Library: Journal of Neuro-Ophthalmology Archives: https://novel.utah.edu/jno/ |
| Publisher |
Lippincott, Williams & Wilkins |
| Holding Institution |
North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416 |
| Rights Management |
© North American Neuro-Ophthalmology Society |
| ARK |
ark:/87278/s60xfw4n |
| Setname |
ehsl_novel_jno |
| ID |
2721556 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s60xfw4n |
